Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

The pathobiology of glioma tumors.

Gladson CL, Prayson RA, Liu WM.

Annu Rev Pathol. 2010;5:33-50. doi: 10.1146/annurev-pathol-121808-102109. Review.

2.

[Genetic and epigenetic markers of gliomas].

Semenova EV, Filatov MV.

Tsitologiia. 2013;55(5):290-9. Review. Russian.

PMID:
24592735
3.

Emerging interplay of genetics and epigenetics in gliomas: a new hope for targeted therapy.

Yong RL, Tsankova NM.

Semin Pediatr Neurol. 2015 Mar;22(1):14-22. doi: 10.1016/j.spen.2014.12.004. Epub 2014 Dec 11. Review.

PMID:
25976256
4.

Molecular pathways triggering glioma cell invasion.

Salhia B, Tran NL, Symons M, Winkles JA, Rutka JT, Berens ME.

Expert Rev Mol Diagn. 2006 Jul;6(4):613-26. Review.

PMID:
16824034
5.

Epigenetic aberrations in malignant gliomas: an open door leading to better understanding and treatment.

Martinez R, Schackert G.

Epigenetics. 2007 Jul-Sep;2(3):147-50. Epub 2007 Sep 15. Review.

PMID:
18063907
6.

Applications of mouse glioma models in preclinical trials.

Hu X, Holland EC.

Mutat Res. 2005 Aug 25;576(1-2):54-65. Review.

PMID:
16011838
7.

Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas.

Nicholas MK, Lukas RV, Jafri NF, Faoro L, Salgia R.

Clin Cancer Res. 2006 Dec 15;12(24):7261-70. Review.

8.

Molecular mechanisms underlying effects of epidermal growth factor receptor inhibition on invasion, proliferation, and angiogenesis in experimental glioma.

Guillamo JS, de Bo√ľard S, Valable S, Marteau L, Leuraud P, Marie Y, Poupon MF, Parienti JJ, Raymond E, Peschanski M.

Clin Cancer Res. 2009 Jun 1;15(11):3697-704. doi: 10.1158/1078-0432.CCR-08-2042. Epub 2009 May 12.

9.

Molecular biomarkers in pediatric glial tumors: a needed wind of change.

Fontebasso AM, Bechet D, Jabado N.

Curr Opin Oncol. 2013 Nov;25(6):665-73. doi: 10.1097/CCO.0000000000000007. Review.

PMID:
24097106
10.

Development of therapeutics for high grade gliomas using orthotopic rodent models.

Frosina G.

Curr Med Chem. 2013;20(26):3272-99. Review.

PMID:
23521683
11.

Epigenetic dysregulation in glioma.

Kondo Y, Katsushima K, Ohka F, Natsume A, Shinjo K.

Cancer Sci. 2014 Apr;105(4):363-9. Review.

12.

Receptor tyrosine kinase signaling in gliomagenesis: pathobiology and therapeutic approaches.

Kapoor GS, O'Rourke DM.

Cancer Biol Ther. 2003 Jul-Aug;2(4):330-42. Review.

PMID:
14508101
13.

Multigene sets for clinical application in glioma.

de Groot JF, Sulman EP, Aldape KD.

J Natl Compr Canc Netw. 2011 Apr;9(4):449-56; quiz 457.

PMID:
21464148
14.

Epigenetic changes in gliomas.

Burgess R, Jenkins R, Zhang Z.

Cancer Biol Ther. 2008 Sep;7(9):1326-34. Epub 2008 Sep 18. Review.

15.

Emerging role of new transgenic mouse models in glioma research.

Sonabend AM, Ulasov IV, Lesniak MS.

Expert Rev Anticancer Ther. 2007 Dec;7(12 Suppl):S7-13. doi: 10.1586/14737140.7.12s.S7. Review.

PMID:
18076321
16.

Gliomas: New Perspectives in Diagnosis, Treatment and Prognosis.

Ghotme KA, Barreto GE, Echeverria V, Gonzalez J, Bustos RH, Sanchez M, Leszek J, Yarla NS, Gomez RM, Tarasov VV, Ashraf GM, Aliev G.

Curr Top Med Chem. 2017;17(12):1438-1447. doi: 10.2174/1568026617666170103162639. Review.

PMID:
28049399
17.

Molecular changes in gliomas.

Sanson M, Thillet J, Hoang-Xuan K.

Curr Opin Oncol. 2004 Nov;16(6):607-13. Review.

PMID:
15627025
18.

Molecular epigenetics and genetics in neuro-oncology.

Nagarajan RP, Costello JF.

Neurotherapeutics. 2009 Jul;6(3):436-46. doi: 10.1016/j.nurt.2009.04.002. Review.

19.

Epigenetics in human gliomas.

Kreth S, Thon N, Kreth FW.

Cancer Lett. 2014 Jan 28;342(2):185-92. doi: 10.1016/j.canlet.2012.04.008. Epub 2012 Apr 21. Review.

PMID:
22531315
20.

Genetic modeling of glioma formation in mice.

Begemann M, Fuller GN, Holland EC.

Brain Pathol. 2002 Jan;12(1):117-32. Review.

PMID:
11770894

Supplemental Content

Support Center